[1]葛文涛,程长生,胡成坤.强心贴联合沙库巴曲缬沙坦对慢性心力衰竭患者脑钠肽水平的影响[J].医学信息,2025,38(04):132-135.[doi:10.3969/j.issn.1006-1959.2025.04.024]
　GE Wentao,CHENG Changsheng,HU Chengkun.Effect of Qiangxin Paste Combined with Sacubitril Valsartan on Brain Natriuretic Peptide Level in Patients with Chronic Heart Failure[J].Journal of Medical Information,2025,38(04):132-135.[doi:10.3969/j.issn.1006-1959.2025.04.024]
点击复制

强心贴联合沙库巴曲缬沙坦对慢性心力衰竭患者脑钠肽水平的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
38卷
期数:
2025年04期
页码:
132-135
栏目:
论著
出版日期:
2025-02-15

文章信息/Info

Title:
Effect of Qiangxin Paste Combined with Sacubitril Valsartan on Brain Natriuretic Peptide Level in Patients with Chronic Heart Failure
文章编号:
1006-1959（2025）04-0132-04
作者:
葛文涛; 程长生; 胡成坤
婺源县人民医院心血管内科，江西 婺源 333200
Author(s):
GE Wentao;  CHENG Changsheng;  HU Chengkun
Department of Cardiovascular Medicine, Wuyuan County People’s Hospital, Wuyuan 333200, Jiangxi, China
关键词:
强心贴; 沙库巴曲缬沙坦; 慢性心力衰竭; 脑钠肽
Keywords:
Qiangxin paste;  Sacubatrol valsartan;  Chronic heart failure;  Brain natriuretic peptide
分类号:
R541.6+1
DOI:
10.3969/j.issn.1006-1959.2025.04.024
文献标志码:
A
摘要:
目的 探究强心贴联合沙库巴曲缬沙坦对慢性心力衰竭患者脑钠肽水平的影响。方法 选取2022年1月-2024年1月婺源县人民医院收治的慢性心力衰竭126例作为研究对象，按照随机数字表法分为对照组和研究组，各63例。所有患者均进行常规治疗，对照组在此基础上给予沙库巴曲缬沙坦钠片治疗，研究组在对照组基础上应用强心贴治疗，比较两组心功能[左室舒张末期内径（LVEDD）、左室射血分数（LVEF）、左室收缩末期内径（LVESD）]、血清脑钠肽水平、6 min步行距离、生活质量（躯体领域、情绪领域、其他）。结果 研究组治疗后LVEDD、LVESD水平均低于对照组，而LVEF水平高于对照组（P＜0.05）；研究组BNP水平低于对照组，而6 min步行距离长于对照组（P＜0.05）；研究组治疗后生活质量评分优于对照组（P＜0.05）。结论 强心贴联合沙库巴曲缬沙坦在慢性心力衰竭患者治疗中的应用效果确切，能够提高患者心功能以及运动耐力，降低血清BNP水平，改善患者生活质量，值得临床应用。
Abstract:
Objective To explore the effect of Qiangxin paste combined with sacubitril valsartan on brain natriuretic peptide level in patients with chronic heart failure. Methods A total of 126 patients with chronic heart failure admitted to Wuyuan County People ’s Hospital from January 2022 to January 2024 were selected as the research objects. According to the random number table method, they were divided into control group and study group, with 63 patients in each group. All patients were given routine treatment. The control group was treated with sacubitril valsartan sodium tablets on this basis. The study group was treated with Qiangxin paste on the basis of the control group. The cardiac function [left ventricular end-diastolic diameter (LVEDD), left ventricular ejection fraction (LVEF), left ventricular end-systolic diameter (LVESD)], serum brain natriuretic peptide level, 6 min walking distance, quality of life (physical field, emotional field, other) were compared between the two groups. Results After treatment, the levels of LVEDD and LVESD in the study group were lower than those in the control group, while the level of LVEF was higher than that in the control group (P<0.05). The BNP level of the study group was lower than that of the control group, while the 6 min walking distance was longer than that of the control group (P<0.05). The quality of life score of the study group after treatment was better than that of the control group (P<0.05). Conclusion Qiangxin paste combined with sacubitril valsartan is effective in the treatment of patients with chronic heart failure. It can improve the cardiac function and exercise endurance of patients, reduce the level of serum BNP, and improve the quality of life of patients. It is worthy of clinical application.

参考文献/References:

[1]殷小金,曾先钦,钟钰灵.芪苈强心胶囊联合重组人脑利钠肽对急性心力衰竭的临床效果[J].深圳中西医结合杂志,2023,33(22):93-96.[2]李萌,闫晓菊,袁兰所,等.伊伐布雷定对肺源性心脏病心力衰竭急性发作期患者近期主要不良心血管事件的影响[J].中华老年心脑血管病杂志,2022,24(1):17-21.[3]赵立君,倪振英,李凤娥,等.强心贴联合氟伐他汀对心力衰竭合并糖尿病患者LVEF、NT-proBNP及TG影响[J].辽宁中医药大学学报,2017,19(11):164-167.[4]赵立君,倪振英,李凤娥,等.中西医结合治疗老年心力衰竭合并2型糖尿病的疗效观察[J].现代生物医学进展,2018,18(16):3123-3126.[5]唐玲,马文欢,冯其茂.强心饮配合综合治疗对慢性充血性心力衰竭老年患者血清中Galectin-3、CyPA及Copeptin水平的影响[J].临床和实验医学杂志,2022,21(1):29-33.[6]徐京育,李宗瑛,叶婷,等.强心胶囊对心力衰竭模型大鼠AngⅡAT1R的影响[J].中国急救医学,2020,40(4):348-351.[7]罗琦.强心饮治疗气虚血瘀证慢性心力衰竭的临床观察[J].中西医结合心脑血管病杂志,2021,19(5):873-875.[8]胡金萍,陈丽云,潘有龙,等.强心饮对慢性心力衰竭模型大鼠超声心动图及心肌细胞凋亡的影响及机制研究[J].时珍国医国药,2023,34(2):296-299.[9]张鞠华,杨波,严世芸,等.强心饮治疗阳虚水泛型慢性心力衰竭疗效观察[J].现代中西医结合杂志,2019,28(23):2541-2543,2552.[10]王甲文,王妍妍,路飞.强心饮联合心脉隆、左卡尼汀治疗慢性心力衰竭患者的疗效及对患者心功能的影响[J].海南医学,2019,30(17):2191-2194.[11]郭李君.磷酸肌酸钠联合强心综合治疗与多巴酚丁胺联合硝酸甘油治疗妊娠合并心力衰竭的效果观察[J].中国妇幼保健,2021,36(7):1473-1476.[12]李琰.强心利水汤治疗冠心病慢性心力衰竭并发水肿[J].中医学报,2021,36(7):1568-1574.[13]滑莹莹,张晓明.强心利水通脉汤治疗慢性心力衰竭利尿剂抵抗的临床研究[J].中华中医药杂志,2020,35(8):4235-4238.[14]沈雁,毛艺霖.强心饮合补阳还五汤加减治疗慢性心力衰竭的临床观察[J].上海中医药大学学报,2020,34(3):14-17.[15]区深恩,关海林,林新宇,等.强心饮经验方联合盐酸曲美他嗪治疗气虚血瘀型慢性心力衰竭46例[J].环球中医药,2018,11(9):1426-1429.[16]周洪伟,张冰,赵海鸿,等.强心通脉汤加减联合西药治疗气虚血瘀型慢性心力衰竭的疗效及安全性分析[J].四川中医,2019,37(12):74-77.[17]郭美珠,秦玉雪,曾洁,等.强心解郁汤联合常规疗法治疗老年慢性心力衰竭合并抑郁症30例[J].上海中医药杂志,2019,53(4):42-44,49.[18]董进军,晋玉梅,祖建国.特色中药内外合治对老年气阴两虚兼血瘀湿阻型慢性心力衰竭影响的临床研究[J].上海中医药杂志,2019,53(1):52-56.[19]高玲,杨婷,王迪,等.强心活力方对慢性心力衰竭大鼠IL-6、TNF-α含量及NF-κB表达的影响[J].中华中医药杂志,2018,33(3):1070-1073.[20]周志强,于海峰,齐燕,等.美托洛尔联合沙库巴曲缬沙坦钠治疗慢性心力衰竭的效果及其对血清NT-proBNP和炎症因子的影响[J].中国老年学杂志,2023,43(9):2070-2073.

相似文献/References:

[1]李 龙,汪莲开.沙库巴曲缬沙坦在心力衰竭治疗中的应用[J].医学信息,2020,33(02):58.[doi:10.3969/j.issn.1006-1959.2020.02.016]
　LI Long,WANG Lian-kai.Application of Shakubatrivasartan in the Treatment of Heart Failure[J].Journal of Medical Information,2020,33(04):58.[doi:10.3969/j.issn.1006-1959.2020.02.016]
[2]袁 超.沙库巴曲缬沙坦联合比索洛尔治疗慢性心力衰竭的效果[J].医学信息,2020,33(19):135.[doi:10.3969/j.issn.1006-1959.2020.19.041]
　YUAN Chao.Effect of Sacubitril Valsartan Combined with Bisoprolol in the Treatment of Chronic Heart Failure[J].Journal of Medical Information,2020,33(04):135.[doi:10.3969/j.issn.1006-1959.2020.19.041]
[3]王晨青,李婧炜.沙库巴曲缬沙坦在心力衰竭中的应用现状[J].医学信息,2021,34(01):37.[doi:10.3969/j.issn.1006-1959.2021.01.011]
　WANG Chen-qing,LI Jing-wei.The Application Status of Sacubatril Valsartan in Heart Failure[J].Journal of Medical Information,2021,34(04):37.[doi:10.3969/j.issn.1006-1959.2021.01.011]
[4]韦怡春,易秋艳.沙库巴曲缬沙坦对心力衰竭患者抑郁的影响[J].医学信息,2021,34(23):29.[doi:10.3969/j.issn.1006-1959.2021.23.008]
　WEI Yi-chun,YI Qiu-yan.Effect of Sacubitril Valsartan on Depression in Patients with Heart Failure[J].Journal of Medical Information,2021,34(04):29.[doi:10.3969/j.issn.1006-1959.2021.23.008]
[5]熊鹏锋.沙库巴曲缬沙坦联合美托洛尔对青年扩张型心肌病患者心功能及预后的影响[J].医学信息,2022,35(20):80.[doi:10.3969/j.issn.1006-1959.2022.20.020]
　XIONG Peng-feng.Effect of Sacubitril Valsartan Combined with Metoprolol on Cardiac Function and Prognosis in Young Patients with Dilated Cardiomyopathy[J].Journal of Medical Information,2022,35(04):80.[doi:10.3969/j.issn.1006-1959.2022.20.020]
[6]龚殿炳.芪苈强心胶囊联合沙库巴曲缬沙坦治疗慢性心力衰竭的临床效果及对心室重构的影响[J].医学信息,2023,36(23):99.[doi:10.3969/j.issn.1006-1959.2023.23.025]
　GONG Dian-bing.Clinical Effect of Qili Qiangxin Capsules Combined with Sacubitril Valsartan in Treatment of Chronic Heart Failure and its Effect on Ventricular Remodeling[J].Journal of Medical Information,2023,36(04):99.[doi:10.3969/j.issn.1006-1959.2023.23.025]

更新日期/Last Update: 1900-01-01